KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Biotech

SK Bioscience: Gates Foundation Funds 4.4 Bln Won for Vaccine R&D

James Jung by James Jung
PUBLISHED: May 19, 2020 UPDATED: May 19, 2020
in Biotech, Coronavirus, Healthcare, Investment, Medical industry, R&D, SK Bioscience, South Korea, Vaccine
0
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.

SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.

On Tuesday, SK Bioscience announces that it would receive 4.4 billion won ($3.6 million) financial backing from the Bill & Melinda Gates Foundation for research and development (R&D) on epidemic countermeasures and COVID-19 vaccine.

A day earlier, the South Korean telecommunications company, KT announced that it also received some 12 billion won ($9.7 million) funding from the Gates Foundation for epidemic preparedness solutions. The company would use artificial intelligence (AI) technology and big data to conduct its ICT-based study.

SK Group’s biotech affiliate, SK Bioscience, plans to collaborate with the U.S.-based alliance, Coalition for Epidemic Preparedness Innovations (CEPI), in conducting non-clinical trials and develop vaccines. SK Bioscience would discuss and review the utilization of the funds with CEPI.

CEPI is a leading antigen design research institute located in the United States. The alliance finances and coordinates the global R&D on new vaccines to prevent and contain infectious diseases.

According to the South Korean biotech, the additional funds from the Gates Foundation would fast track the urgency for effective and fair priced COVID-19 vaccines. The company earlier received a 100 million won ($81,000) investment from the government to engage in the vaccine development project.

SK Bioscience plans to use three of its existing platforms to determine several COVID-19 vaccine candidates. The company expects CEPI to help secure several vaccines with higher immunogenicity.

Expertise and Commitment

Ahn Jae-yong, CEO of SK Bioscience, said that the company believes that it would quickly enter the clinical trial stage. He said that the company’s capabilities stems from its extensive experience in the development and commercialization of various vaccines.

He added that SK Bioscience’s collaboration with the Gates Foundation testifies to its technology expertise and commitment.

In the past, SK Bioscience partnered with the Bill & Melinda Gates Foundation to develop vaccines for typhoid and pediatric enteritis.

Ahn said that the company would concentrate all of its capabilities on the research and development of a COVID-19 vaccine.

Tags: $3.6 million4.4 billion wonBill & Melinda Gates FoundationCEPICOVID-19fundR&DSKSK Biosciencevaccine

Related Posts

Chazm Operator Wins Scale-up TIPS Selection to Expand Automotive Finance AI
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.
AI

Chazm Operator Wins Scale-up TIPS Selection to Expand Automotive Finance AI

November 4, 2026
Why the Future of Digital Healthcare May Be Built Around Families, Not Just Patients
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.
Healthcare

Why the Future of Digital Healthcare May Be Built Around Families, Not Just Patients

November 1, 2026
Why Healthcare Technology Must Adapt to How People Actually Live
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.
Healthcare

Why Healthcare Technology Must Adapt to How People Actually Live

November 1, 2026
The Strategic Investment Trap: What Korean Startup Founders Should Consider Before Taking Corporate VC
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.
AI

The Strategic Investment Trap: What Korean Startup Founders Should Consider Before Taking Corporate VC

November 1, 2026
India and South Korea Could Build a New Startup Corridor Around Manufacturing and Technology
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.
South Korea

India and South Korea Could Build a New Startup Corridor Around Manufacturing and Technology

November 1, 2026
Why South Korea Could Become a Strategic Growth Partner for Southeast Asian Startups
SK Bioscience receives funding from the Bill & Melinda Gates Foundation for the R&D of COVID-19 vaccine.
South Korea

Why South Korea Could Become a Strategic Growth Partner for Southeast Asian Startups

November 1, 2026
No Result
View All Result

Most Popular

  • Naver Pay Reaches 30.68 Million Users, Expands Global and Local Payment Services

    0 shares
    Share 0 Tweet 0
  • Why South Korea’s Hyperconnected Economy Needs a More Integrated Cybersecurity Strategy

    0 shares
    Share 0 Tweet 0
  • Kakao in Talks to Sell Daum, With AI Startup Upstage as Top Contender

    0 shares
    Share 0 Tweet 0
  • Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants

    0 shares
    Share 0 Tweet 0
  • Kakao Mobility Faces $10.5 Million Fine for Limiting Competitors’ Access to Taxi Platform

    0 shares
    Share 0 Tweet 0
  • LG Uplus Introduces OpenAI-Powered Agentic Callbot for Customer Phone Support

    0 shares
    Share 0 Tweet 0

PRODUCTS

[ads_amazon]

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

[mc4wp_form id="4726"]

FOLLOW US

  • About Us
  • Cookie policy
  • home
  • homepage
  • mainhome
  • Our Services
  • Privacy Policy
  • Terms of Use

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |